Lumos Diagnostics Holdings Limited LDXHF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -4.95M | -7.11M | -9.26M | -8.22M | -7.18M |
| Total Depreciation and Amortization | 1.70M | 1.65M | 1.60M | 1.64M | 1.67M |
| Total Amortization of Deferred Charges | 850.00K | 852.00K | 854.00K | 854.00K | 854.00K |
| Total Other Non-Cash Items | -1.09M | 4.45M | 9.98M | 5.36M | 748.00K |
| Change in Net Operating Assets | 4.51M | -460.50K | -5.43M | -5.43M | -5.43M |
| Cash from Operations | 1.01M | -620.00K | -2.25M | -5.79M | -9.33M |
| Capital Expenditure | -2.54M | -1.38M | -222.00K | -137.50K | -53.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -2.54M | -1.38M | -222.00K | -137.50K | -53.00K |
| Total Debt Issued | 688.00K | 344.00K | -- | -- | -- |
| Total Debt Repaid | -1.73M | -1.38M | -1.02M | -984.50K | -946.00K |
| Issuance of Common Stock | 18.61M | 9.79M | 964.00K | 3.59M | 6.22M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.34M | -1.17M | -- | -- | -- |
| Cash from Financing | 15.23M | 7.59M | -59.00K | 2.61M | 5.28M |
| Foreign Exchange rate Adjustments | -232.00K | -117.50K | -3.00K | -207.50K | -412.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 13.47M | 5.47M | -2.54M | -3.53M | -4.52M |